Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
IVVD
#2830
Invivyd, Inc. Common Stock
1.6
9
-1.17%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
-1.17%
Monthly Change
-17.56%
6 month change
+74.23%
Year Change
+40.83%
Previous Close
1.7
1
Open
1.6
9
Bid
Ask
Low
1.6
9
High
1.6
9
Volume
53
Markets
US Stock Market
Healthcare
IVVD
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
109.68 M
109.19 M
119.22 M
119.96 M
—
Valuation ratios
Enterprise value
—
77.17 M
234.52 M
-16.19 M
230.81 M
Price to earnings ratio
—
-0.7
-2.02
-0.31
-4
Price to sales ratio
—
—
—
2.07
8.73
Price to cash flow ratio
—
0.76
2.31
0.31
3.26
Price to book ratio
—
0.47
2.25
0.78
1.9
Enterprise value to EBITDA ratio
—
—
—
0.09
—
Profitability ratios
Return on assets %
0.37
0.63
0.87
1.31
0.54
Return on equity %
0.41
0.68
1.12
2.52
1.03
Return on invested capital %
5 741.96
699.99
622.46
3 936.81
937.02
Gross margin %
—
—
—
94.22
387.03
Operating margin %
—
—
—
696.8
500.58
EBITDA margin %
—
—
—
-702.58
—
Net margin %
—
—
—
669.42
481.68
Liquidity ratios
Quick ratio
—
—
—
1.21
4.88
Current ratio
9.94
15.06
4.47
1.62
6.95
Inventory turnover
—
—
—
0.06
0.06
Asset turnover
—
—
—
0.14
0.43
Solvency ratios
Debt to assets ratio
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
Long term debt to total assets ratio
—
2.61
4.36
7.72
35.76
Long term debt to total equity ratio
—
2.81
5.63
14.81
67.39
Per share metrics
Operating cash flow per share
4.33
2.03
1.58
1.44
0.65
EBIT per share
—
—
—
-1.5
-0.48
EBITDA per share
—
—
—
-1.5
—
Total debt per share
—
—
—
—
—
Cash per share
12.72
0.85
1.83
0.58
1.78
Net current asset value per share
14.47
3.48
2.05
0.85
2.62
Tangible book value per share
13.09
3.29
1.62
0.57
1.92
Working capital per share
13.01
3.25
1.59
0.33
1.05
Book value per share
13.09
3.29
1.62
0.57
1.92
News
MannKind (MNKD) Reports Q4 Loss, Tops Revenue Estimates
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
Invivyd (IVVD) CHRO Green sells $63k in stock after option exercise
Invivyd CSO Allen sells shares worth $58,600
Halozyme Therapeutics (HALO) Reports Q4 Loss, Tops Revenue Estimates
H.C. Wainwright reiterates Buy rating on Invivyd stock amid FDA feedback
Invivyd receives FDA feedback on COVID antibody vs mRNA vaccine trial
H.C. Wainwright reaffirms Buy rating on Invivyd stock ahead of key trial data
Invivyd stock rises after partnering with Olympic champion Lindsey Vonn
Invivyd partners with ski champion Lindsey Vonn on antibody education
Invivyd stock maintains Buy rating at BTIG on Long COVID treatment potential
Invivyd to begin phase 2 trial of antibody therapy for long COVID